Norges Bank Investment Management »

Peregrine Pharmaceuticals shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 181k 6.50
2022-09-30 $4.5M 235k 19.12
2022-06-30 $4.1M 269k 15.26
2021-09-30 $1.3M 61k 21.56
2021-06-30 $1.0M 40k 25.66
2020-12-31 $2.3M 197k 11.54